PredictImmune announces PredictSURE IBD study
The jointly-sponsored study aims to validate PredictSURE IBD – the company’s first prognostic test for inflammatory bowel disease, in the US market.
7th November 2019
Latest news
EMA validates Braftovi, Mektovi application for some mCRC
Currently, there are limited treatment options available that can prolong the lives of metastatic colorectal cancer patients.
7th November 2019
Bemcentinib, Keytruda combo hits endpoints in mid-stage NSCLC trial
Bemcentinib, formerly known as BGB324, is a potentially first-in-class selective AXL inhibitor.
7th November 2019
Vifor Pharma, Evotec venture in to nephrology therapeutics
The partnership will enable Vifor to identify new targets for renal therapies to bolster the company's pipeline.
7th November 2019
First national medical cannabis registry launched
Despite the legislation of cannabis being passed a year ago, it remains out of reach for the vast majority of patients.
7th November 2019
FDA grants Sandoz approval for Ziextenzo in oncology care
The drug has been approved and marketed in Europe as Ziextenzo since 2018.
6th November 2019
The return of NICE international
The initiative provides support in developing systems to improve health and social care evidence-based decision making.
6th November 2019
NHS reveals online training for speedier hospital dismissal
The new platform is called ActNow, and people "get back to the comfort of their own home quicker."
6th November 2019
AZ launch new medicine research, development centres in China
The Global R&D Centre will carry out R&D for potential new innovative medicines, and more than double AstraZeneca’s Shanghai R&D headcount to around 1,000.
6th November 2019
Mission Bio launches Tapestri Platform to identify accurate cancer targets
The technology is the first-of-its-kind, detecting DNA and protein changes simultaneously.
6th November 2019
Awards evening approaching for the Communications Team of the Year, Marketer and Sales Awards
The awards ceremony for the 2019 competition’s will be taking place on the 14th November at the Chelsea Harbour Hotel.
6th November 2019
As AMR threat grows, GPs reduce antibiotic use
Antimicrobial resistance could cause as many as 10 million deaths per year by 2050.
5th November 2019
Heart failure hospital admissions shoot up by 1/3
the British Heart Foundation has announced the launch a new £1million Hope for Hearts Fund, to test innovative ways of caring for people with heart failure.
5th November 2019
"Molecular profiling" could be key to new liver disease treatments
Identifying new treatments for liver scarring is “critical” to tackling the epidemic of liver disease.
5th November 2019
Refining blood tests could help detect heart failure
The proposed improvement could cut costs and save patients avoidable trips to their GP.
5th November 2019
